OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+0.53%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$153M
AUM Growth
+$153M
Cap. Flow
-$122M
Cap. Flow %
-79.49%
Top 10 Hldgs %
97.34%
Holding
16
New
–
Increased
–
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

1
IMGO
Imago BioSciences, Inc. Common stock
IMGO
$109M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
$7.85M
3
REPL icon
Replimune Group
REPL
$5.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
REPL icon
1
Replimune Group
REPL
$422M
$53.9M 35.13% 3,050,187 -311,619 -9% -$5.5M
NUVB icon
2
Nuvation Bio
NUVB
$1.02B
$25M 16.32% 15,072,340 – –
MORF
3
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$22.5M 14.67% 597,723 – –
ALPN
4
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$15.7M 10.22% 2,029,580 – –
IMA
5
ImageneBio, Inc. Common Stock
IMA
$150M
$7.76M 5.06% 2,249,123 – –
THRX
6
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$6.32M 4.12% 711,479 – –
KRON
7
DELISTED
Kronos Bio
KRON
$5.57M 3.64% 3,818,283 – –
PRTK
8
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.01M 3.27% 1,971,241 – –
SPRB
9
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$4.78M 3.11% 2,161,022 – –
SANA icon
10
Sana Biotechnology
SANA
$777M
$2.76M 1.8% 843,750 – –
IMUX icon
11
Immunic
IMUX
$80.9M
$2.66M 1.74% 1,788,160 – –
SYRS
12
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$671K 0.44% 251,270 – –
JNCE
13
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$510K 0.33% 275,513 – –
SNTI icon
14
Senti Biosciences
SNTI
$38.5M
$231K 0.15% 195,792 – –
CINC
15
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– – -560,985 Closed -$7.85M
IMGO
16
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
– – -3,018,737 Closed -$109M